This is is part of my live-learning series! I will be updating this post as I continue through my journey. I apologize for any grammatical errors or incoherent thoughts. This is a practice to help me share things that are valuable without falling apart from the pressure of perfection. 

“Usona Institute – About Us

“Our objective is to find new and effective methods to relieve anxiety and suffering, and contribute to the understanding of neuroscience and the relationship of the mind and body. This is a frontier of research that will shape our future in important ways that we are just beginning to appreciate.”

—Bill Linton, Executive Director & Co-Founder

Usona Institute is a 501(c)(3) non-profit medical research organization dedicated to supporting and conducting pre-clinical and clinical research to further the understanding of the therapeutic effects of psilocybin and other consciousness-expanding medicines. Our focus is on alleviating depression in people for whom current medical treatments fall short in offering relief and a better quality of life.

Based in Madison, Wisconsin, Usona was founded in 2014 by Bill Linton, CEO and Founder of the international life sciences company Promega Corporation, and Malynn Utzinger, M.D., Director of Integrative Practices at Promega Corporation. The Institute was founded shortly after Bill was inspired by the meaningful impact that a psilocybin study at Johns Hopkins University had on a friend suffering from cancer.

To learn more about how Usona came to be founded as a non-profit medical research organization, please see the video below featuring Director of Integrative Medicine & Co- Founder Malynn Utzinger, M.D.


D’Or Institute for Research and Education (IDOR)

Hans Knöll Institute

Imperial College London

Heffter Research Institute

MAPS Public Benefit Corporation

Swiss Neuromatrix Foundation

University of Wisconsin Hospital and Clinics

University of Wisconsin–Madison School of Pharmacy

Michael Bogenschutz, MD, New York University

Robin Carhart-Harris, PhD, Imperial College London

Roland Griffiths, PhD, Johns Hopkins University School of Medicine

Charles Grob, MD, Harbor-UCLA Medical Center

Dirk Hoffmeister, PhD, Friedrich Schiller University and Hans Knöll Institute

Matthew Johnson, PhD, Johns Hopkins University School of Medicine

Benjamin Kelmendi, MD, Yale School of Medicine

Janis Phelps, PhD, CIIS Center for Psychedelic Therapies and Research

Stephen Ross, MD, New York University

Franz Vollenweider, MD, University of Zürich

Joshua Woolley, MD, PhD, UCSF School of Medicine

Statement on Collaboration

Usona Institute is able to accomplish its mission of enabling and supporting psychedelic research and FDA registration of psilocybin therapy only through collaboration with many scientists, clinicians, research centers, expert consultants, and philanthropists globally.

Usona will continue to build relationships and collaborations with all organizations that share our philosophy of delivering approved therapies to those in need based on safety, high quality active drug materials, and highly-trained guides and practitioners, at the lowest possible cost.

Usona is building an advanced chemistry capability with our cGMP contract suppliers and through approved research chemistry facilities at two locations in the United States. High quality materials will be supplied to qualified research and therapy centers for basic, applied, and clinical research at cost or gratis, for the purpose of accelerating the pace of research for these important therapies.

Expertise on the Usona team includes:

Study design and protocol development

ICH GCP (Good Clinical Practice) compliance

FDA drug development

Clinical research leadership

Multi-site drug development management

Contract research organization (CRO) management

CIIS-trained guide expertise

Complex clinical drug development program management

Small molecule design and scale-up with full analytical capabilities

Preclinical safety and pharmacology research

Translational methodologies

Navigation of regulatory agencies and requirements


Public health policy

Open Science

As a non-profit medical research organization, Usona Institute is dedicated to working for the public good through the advancement of scientific knowledge and the alleviation of mental suffering. Guided by this purpose, Usona—along with a collection of like-minded organizations, scientists, practitioners, and philanthropists—has signed a statement to make public the scientific discoveries and processes that arise from its research.

We believe that openness, transparency, and collaboration will move this field of scientific knowledge forward most efficiently and honorably, and we are pleased to commit ourselves to this approach.”

Learn more at

More To Explore


Founder Wealth

Interested in Founder Wealth? Check out the latest video and resources from Tyler Bryden on Founder Wealth!

Read More »

Share This Post

Join My Personal Newsletter ❤

Get insights and resources into awareness, well-being, productivity, technology, psychedelics and more.

Don't want to chat but want to keep updated?

I'd love if you subscribed today. I promise I will only send you great, valuable content that has transformed me and helped others flourish. 

You have Successfully Subscribed!

Pin It on Pinterest